Epidemiology and carbapenem resistance mechanisms of carbapenem-non-susceptible Pseudomonas aeruginosa collected during 2009-11 in 14 European and Mediterranean countries

Biological Markers of Pseudomonas aeruginosa Epidemic High-Risk Clones

(2013) Xavier Mulet et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IMP-33, a New IMP Variant Detected in Pseudomonas aeruginosa from Sicily

(2013) Lalitagauri M. Deshpande et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Accumulation of carbapenem resistance mechanisms in VIM-2-producing Pseudomonas aeruginosa under selective pressure

(2013) G. Meletis et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Complexity of resistance mechanisms to imipenem in intensive care unit strains of Pseudomonas aeruginosa

(2013) Damien Fournier et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Genetic Markers of Widespread Extensively Drug-Resistant Pseudomonas aeruginosa High-Risk Clones

(2012) Gabriel Cabot et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Overexpression of AmpC and Efflux Pumps in Pseudomonas aeruginosa Isolates from Bloodstream Infections: Prevalence and Impact on Resistance in a Spanish Multicenter Study

(2011) Gabriel Cabot et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem

(2011) E. Riera et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Most Multidrug-Resistant Pseudomonas aeruginosa Isolates from Hospitals in Eastern France Belong to a Few Clonal Types

(2011) Pascal Cholley et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Wide Dispersion of ST175 Clone despite High Genetic Diversity of Carbapenem-Nonsusceptible Pseudomonas aeruginosa Clinical Strains in 16 Spanish Hospitals

(2011) M. Garcia-Castillo et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Population Structure of Pseudomonas aeruginosa from Five Mediterranean Countries: Evidence for Frequent Recombination and Epidemic Occurrence of CC235

(2011) Makaoui Maatallah et al.   PLoS One

Hydrolysis and Inhibition Profiles of  -Lactamases from Molecular Classes A to D with Doripenem, Imipenem, and Meropenem

(2009) A. M. Queenan et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Molecular Epidemiology and Mechanisms of Carbapenem Resistance in Pseudomonas aeruginosa

(2009) J.-M. Rodriguez-Martinez et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Multidrug-Resistant Gram-Negative Infections

(2009) Helen Giamarellou et al.   DRUGS

Has the era of untreatable infections arrived?

(2009) D. M. Livermore   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

First Countrywide Survey of Acquired Metallo- -Lactamases in Gram-Negative Pathogens in Italy

(2008) G. M. Rossolini et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Evaluation of isolation methods and RNA integrity for bacterial RNA quantitation

(2008) Courtney E. Jahn et al.   JOURNAL OF MICROBIOLOGICAL METHODS